Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-17

FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for valacyclovir hydrochloride submitted by Jubilant Cadista Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir hydrochloride (valacyclovir hydrochloride)

Snippet

SUPPL AP for VALACYCLOVIR HYDROCHLORIDE (VALACYCLOVIR HYDROCHLORIDE)